Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Net revenues	$ 6,586,144	$ 1,529,262	$ 8,950,160	$ 3,744,824
Costs and expenses:
Cost of revenues	5,859,370	2,832,735	11,323,668	8,105,422
Research and development expenses	1,087,741	1,163,546	3,989,133	3,535,116
General and administrative expenses	3,023,337	1,700,380	6,839,467	5,058,525
Sales and marketing expenses	1,434,481	1,462,335	4,232,867	4,451,628
Total costs and expenses	11,404,929	7,158,996	26,385,135	21,150,691
Loss from operations	(4,818,785)	(5,629,734)	(17,434,975)	(17,405,867)
Other income/ (expense):
Interest expense	(59,549)	(62,028)	(171,891)	(187,575)
Warrant inducement and other income (expenses)			(2,102,109)	(1,831,116)
Total other income/ (expense):	(59,549)	(62,028)	(2,274,000)	(2,018,691)
Loss before income taxes	(4,878,334)	(5,691,762)	(19,708,975)	(19,424,558)
Net loss and comprehensive loss	(4,878,334)	(5,691,762)	(19,708,975)	(19,424,558)
Deemed dividend related to warrants down round provision			(2,774)	(99,743)
Net loss attributable to common shareholders	$ (4,878,334)	$ (5,691,762)	$ (19,711,749)	$ (19,524,301)
Weighted-average shares outstanding used in computing net loss per share attributable to common shareholders:
Basic	11,324,289	2,301,819	13,333,427	1,780,727
Diluted	11,324,289	2,301,819	13,333,427	1,780,727
Net loss per common share:
Basic	$ (0.43)	$ (2.47)	$ (1.48)	$ (10.96)
Diluted	$ (0.43)	$ (2.47)	$ (1.48)	$ (10.96)